Mastodon

Inulin Forte Evalar (Tablets) Instructions for Use

Marketing Authorization Holder

Evalar, CJSC (Russia)

Dosage Forms

Bottle OTC Icon Inulin Forte Evalar Tablets
Coated Tablets

Dosage Form, Packaging, and Product Composition

Composition inulin, gymnema extract, microcrystalline cellulose, aerosil, calcium or magnesium stearate.

Content of biologically active substances in 1 tablet, not less than inulin 250 mg/tablet weighing 0.52 g or 500 mg/tablet 1 g.

Dosage form and packaging
Tablets 0.52 g or 0.1 g. Coated tablets, 0.52 g or 0.1 g.
100 tablets in a bottle, 1 bottle in a cardboard pack.

Therapeutic Category

Dietary supplement for the correction of metabolism

Scope of Application

Of the product Inulin Forte Evalar

Recommended as a dietary supplement – a source of inulin.

Indications

  • Use as a source of inulin to support metabolic processes.
  • Employ for dietary management in cases of nutritional deficiency as part of a balanced diet.
  • Intended for use in adults seeking to supplement their daily intake of prebiotic fiber.

ICD codes

ICD-10 code Indication
E63.8 Other specified types of nutritional deficiency
ICD-11 code Indication
5B7Z Malnutrition, unspecified
8D40.0 Encephalopathy due to nutritional deficiency

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take orally with meals to improve tolerance and absorption. Administer two tablets of 0.52 g or one tablet of 1.0 g twice daily.

Adhere to a continuous intake period of 25 days. For long-term use, implement a cyclical pattern with a 5-day break between courses. Do not exceed the recommended daily dosage.

Adverse Reactions

Monitor for signs of individual intolerance, which may include gastrointestinal discomfort such as bloating or flatulence, especially during initial use.

Discontinue use immediately and consult a healthcare professional if any allergic reactions or other adverse effects occur. The likelihood of side effects is generally low but increases with sensitivity to any component.

Drug Interactions and Concomitant Use Precautions

No specific pharmacokinetic drug interactions are known. Exercise caution when taking with other fiber supplements or medications, as inulin may affect the absorption rate of concurrently administered oral drugs.

Maintain a time interval of at least 2 hours between taking this supplement and other medications to minimize potential interaction. Consult a physician if you are on any long-term pharmacotherapy.

Contraindications and Patient Populations for Exclusion

  • Absolute contraindications include confirmed hypersensitivity to inulin, gymnema extract, or any excipient in the formulation.
  • Do not use during pregnancy or breastfeeding due to the absence of safety data for these populations.
  • Exercise caution and seek medical advice in individuals with severe gastrointestinal disorders such as fructose intolerance or irritable bowel syndrome.

Overdose Management and Symptoms of Excessive Intake

No data available on acute overdose. Excessive consumption may lead to pronounced gastrointestinal distress, including severe bloating, cramping, or diarrhea.

In case of suspected overdose, discontinue use immediately and initiate symptomatic and supportive care. Ensure adequate hydration. Seek medical attention if symptoms are severe or persistent.

Dispensing Status

Sold to the public through pharmacy chains and specialized stores, departments of the retail network.

Storage Conditions

Store at a temperature not exceeding +25 C.

Shelf Life

Shelf life – 2 years.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS